Mediwhale
PrivateLast Round
Series C
Mar 31, 2026
Total Funding Raised
$36.3M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Mediwhale operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was a Series C round in March 2026.
Mediwhale is a healthcare technology company that specializes in artificial intelligence-driven diagnostics to assess health risks via retinal scans for the early detection of cardiovascular, kidney, and eye diseases, facilitating preventive care in primary care environments.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Medical Devices, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mediwhale Comparables
Compare Mediwhale with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| iHealthScreen Inc. | 84% | |
| Eyenuk | 81% | |
| Digital Diagnostics | 81% |
For institutional investors. Book with your work email.
Mediwhale Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Mar 31, 2026 | ||||
| Series A Extension | Sep 25, 2024 | ||||
| Series A | Mar 29, 2023 | ||||
| Pre Seed | Aug 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Mediwhale Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hana Ventures | Series C |
| IMM Investment | Series C |
| KB Investment | Series C |
| HTA | Series A |
| SBI Investment Korea | Series A, Pre Seed |
| Premier Partners | Series C |
| Mirae Asset Securities | Series A Extension |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2026
Monthly visitors grew 53% MoM to 10.8K.
- Mar 31, 2026
$13.3M round completed.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- has_revenueSep 2, 2026
In 2025, Mediwhale Inc.'s revenue reaches $5M.
For institutional investors. Book with your work email.
Mediwhale Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Mediwhale's valuation, stock price, and market status.
Is Mediwhale a public or private company?
Mediwhale is a private company.
What is the current stock price of Mediwhale?
Mediwhale is a private company, so its shares have no public market price. Caplight tracks Mediwhale's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Mediwhale worth (valuation)?
Valuation information for Mediwhale is not publicly available.
Can I buy Mediwhale stock?
Mediwhale shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Mediwhale's last funding round?
Mediwhale's most recent funding round was Series C on March 31, 2026.
Who are the main investors in Mediwhale?
Key investors in Mediwhale include SBI Investment Korea, Premier Partners, Korea Development Bank, SBI Investment Co., Ltd..
Will Mediwhale IPO soon?
No public IPO plans have been announced for Mediwhale.
How can I track Mediwhale secondary market activity?
Caplight tracks bids, offers, and trades in Mediwhale's shares on secondary markets.